Inequities in Access to Biologic Disease-Modifying Anti-Rheumatic Drugs for Patients with Rheumatoid Arthritis Across 46 European Countries.
AuthID
P-002-4R1
P-002-4R1
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service